-
Research funding: None declared.
-
Author contribution: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: Not applicable.
References
1. Bayat, H, Johansen Vesper, V, Bachmann, L, Person, N. Limitations in using the EFLM WG-A/ISO approach for assessment of reagent lot variability. Clin Chem Lab Med 2023;61:e215–7.10.1515/cclm-2023-0430Search in Google Scholar PubMed
2. van Schrojenstein Lantman, M, Çubukçu, HC, Boursier, G, Panteghini, M, Bernabeu-Andreu, FA, Milinkovic, N, et al.. An approach for determining allowable between reagent lot variation. Clin Chem Lab Med 2022;60:681–8. https://doi.org/10.1515/cclm-2022-0083.Search in Google Scholar PubMed
3. CLSI. User evaluation of between-reagent lot variation. In: Approved guideline. CLSI document EP26-A. Wayne PA: Clinical and Laboratory Standards Institute; 2013.Search in Google Scholar
4. Algeciras-Schimnich, A, Bruns, DE, Boyd, JC, Bryant, SC, La Fortune, KA, Grebe, SK. Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions. Clin Chem 2013;59:1187–94. https://doi.org/10.1373/clinchem.2013.205070.Search in Google Scholar PubMed
5. Katzman, BM, Ness, KM, Algeciras-Schimnich, A. Evaluation of the CLSI EP26-A protocol for detection of reagent lot-to-lot differences. Clin Biochem 2017;50:768–71. https://doi.org/10.1016/j.clinbiochem.2017.03.012.Search in Google Scholar PubMed
6. Thompson, S, Chesher, D. Lot-to-lot variation. Clin Biochem Rev 2018;39:51–60.Search in Google Scholar
7. Kim, S, Chang, J, Kim, S-K, Park, S, Huh, J, Jeong, T-D. Sample size and rejection limits for detecting reagent lot variability: analysis of the applicability of the Clinical and Laboratory Standards Institute (CLSI) EP26-A protocol to real-world clinical chemistry data. Clin Chem Lab Med 2020;59:127–38. https://doi.org/10.1515/cclm-2020-0454.Search in Google Scholar PubMed
8. To, M, Raizman, JE, Goudreau, BL, Higgins, T, Brun, M, Tsui, AKY. Centralization of multisite reagent lot-to-lot validation for ortho clinical vitros chemistry instruments. Clin Biochem 2021;97:62–6. https://doi.org/10.1016/j.clinbiochem.2021.07.017.Search in Google Scholar PubMed
9. Loh, TP, Sandberg, S, Horvath, AR. Lot-to-lot reagent verification: challenges and possible solutions. Clin Chem Lab Med 2022;60:675–80. https://doi.org/10.1515/cclm-2022-0092.Search in Google Scholar PubMed
10. CLSI. User evaluation of acceptability of a reagent lot change. In: CLSI guideline EP26, 2nd ed. Clinical and Laboratory Standards Institute; 2022.Search in Google Scholar
11. Plebani, M, Zaninotto, M. Lot-to-lot variation: no longer a neglected issue. Clin Chem Lab Med 2022;60:645–6. https://doi.org/10.1515/cclm-2022-0128.Search in Google Scholar PubMed
12. Krintus, M, Panteghini, M. Judging the clinical suitability of analytical performance of cardiac troponin assays. Clin Chem Lab Med 2023;61:801–10. https://doi.org/10.1515/cclm-2023-0027.Search in Google Scholar PubMed
13. Badrick, T, Ward, G, Hickman, P. The effect of the immunoassay curve fitting routine on bias in troponin. Clin Chem Lab Med 2022;61:188–95. https://doi.org/10.1515/cclm-2022-0657.Search in Google Scholar PubMed
14. Kavsak, PA. Lot-to-lot bias for high-sensitivity cardiac troponin I concentrations ≥1000 ng/L. Clin Chem Lab Med 2023;61:e105–7. https://doi.org/10.1515/cclm-2023-0017 [Epub ahead of print].Search in Google Scholar PubMed
15. Braga, F, Pasqualetti, S, Aloisio, E, Panteghini, M. The internal quality control in the traceability era. Clin Chem Lab Med 2020;59:291–300. https://doi.org/10.1515/cclm-2020-0371.Search in Google Scholar PubMed
16. Braga, F, Panteghini, M. Commutability of reference and control materials: an essential factor for assuring the quality of measurements in laboratory medicine. Clin Chem Lab Med 2019;57:967–73. https://doi.org/10.1515/cclm-2019-0154.Search in Google Scholar PubMed
17. Miller, WG, Greenberg, N, Panteghini, M, Budd, JR, Johansen, JV. Guidance on which calibrators in a metrologically traceable calibration hierarchy must be commutable with clinical samples. Clin Chem 2023;69:228–38. https://doi.org/10.1093/clinchem/hvac226.Search in Google Scholar PubMed
© 2023 Walter de Gruyter GmbH, Berlin/Boston
